Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein

Microbiology Spectrum(2022)10.1128/spectrum.02676-21Source: DataRank Database

Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.10)OA: goldTopics (52)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Dana Bohan ORCID,Kai J. Rogers ORCID,Mohammad Fili ORCID,Roberth Anthony Rojas Chávez ORCID,Enya Qing ORCID

Live enrichment

PubMed:35080430 OpenAlex:https://openalex.org/W4225673515

HHS | National Institutes of Health

Grant: R01AI134733

HHS | National Institutes of Health

Grant: T32AI007511

HHS | National Institutes of Health

Grant: R21AI144215

HHS | National Institutes of Health

Grant: T32GM007337

NIAID NIH HHS

Grant: T32 AI007485

NIGMS NIH HHS

Grant: T32 GM139776

BLRD VA

Grant: I01 BX000207

NIAID NIH HHS

Grant: T32 AI007343

FWCI

0.10

Citation Percentile

0.4%

Citation Trend

2023

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.02676-21

publisherhttps://doi.org/10.1128/spectrum.02676-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.02676-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35080430

repositoryhttps://doaj.org/article/d91f201a1a454c09a2b3fe510f6ca70b

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections StudiesAntibodies, NeutralizingAntibodies, ViralAntibody FormationCOVID-19Enzyme-Linked Immunosorbent AssayHumansNeutralization TestsProtein DomainsSARS-CoV-2Spike Glycoprotein, Coronavirus

MeSH Terms

Protein DomainsCOVID-19SARS-CoV-2Antibodies, ViralAntibody FormationEnzyme-Linked Immunosorbent AssayHumansNeutralization TestsAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

AntibodyNeutralizationPolyclonal antibodiesVirologyGlycoproteinVirusPotencyBiologySpike (software development)CoronavirusImmunologyMedicineMolecular biologyCoronavirus disease 2019 (COVID-19)DiseaseGeneticsInternal medicineCOVID-19N-terminal domainSARS-CoV-2adaptive immunityantibody neutralizationconvalescent-phase plasmaimmunoassayimmunoglobulinsneutralizing antibodiesreceptor-binding domainspike glycoproteinspike protein

Sustainable Development Goals

SDG 0: Good health and well-being